- According to estimates from 8 analysts, Agios Pharmaceuticals, Inc. stock's average price target has risen from $42.75 to $43.12, with forecasts ranging from $31 to $62 per share
- Based on the Jul. 29 closing price, the updated target implies approximately 23% potential upside
- Consensus rating remains at “Buy” across 10 covering analysts, with 7 Buys, 3 Holds and 0 Sells
Explore more price target data and ratings for Agios Pharmaceuticals, Inc. on the , and track all previous and future analyst recommendations for Agios Pharmaceuticals, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.